# Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer

> **NCT00002498** · PHASE2 · UNKNOWN · sponsor: **Leiden University Medical Center**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** CMF regimen
- **DRUG:** cyclophosphamide
- **DRUG:** fluorouracil
- **DRUG:** methotrexate
- **DRUG:** mitoxantrone hydrochloride

## Key facts

- **NCT ID:** NCT00002498
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1992-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002498, "Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00002498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*